Holding(s) in Company

RNS Number : 3601N

Spire Healthcare Group PLC

25 July 2014

 



TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES

1.   Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Spire Healthcare Group plc

2. Reason for the notification (please state Yes/No):

An acquisition or disposal of voting rights: (YES)

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached:

An event changing the breakdown of voting rights: (    )

Other (please specify)

3. Full name of person(s) subject to the notification obligation:

Cinven Limited
Cinven S.A

4. Full name of shareholder(s) (if different from 3.):

FOURTH CINVEN FUND (NO.1) LIMITED PARTNERSHIP

FOURTH CINVEN FUND (NO.2) LIMITED PARTNERSHIP

FOURTH CINVEN FUND (NO.3-VCOC) LIMITED PARTNERSHIP

FOURTH CINVEN FUND (NO.4) LIMITED PARTNERSHIP

FOURTH CINVEN FUND (UBTI) LIMITED PARTNERSHIP

FOURTH CINVEN FUND FCPR

FOURTH CINVEN FUND CO-INVESTMENT PARTNERSHIP

FOURTH CINVEN (MACIF) LIMITED PARTNERSHIP

5. Date of the transaction (and date on which the threshold is crossed or reached if different): 23 July 2014

6. Date on which issuer notified: 24 July 2014

7. Threshold(s) that is/are crossed or reached: 3%

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction		Resulting situation after the triggering transaction
	Number of Shares	Number of Voting Rights	Number of shares	Number of voting rights			% of  voting rights x
			Direct	Direct xi		Indirect xii	Direct	Indirect
ORDINARY ISIN: GB00BNLPYF73
FOURTH CINVEN FUND (NO.1) LIMITED PARTNERSHIP	0	0	43,914,666	43,914,666			10.95%
FOURTH CINVEN FUND (NO.2) LIMITED PARTNERSHIP	0	0	45,820,729	45,820,729			11.42%
FOURTH CINVEN FUND (NO.3-VCOC) LIMITED PARTNERSHIP	0	0	45,429,522	45,429,522			11.33%
FOURTH CINVEN FUND (NO.4) LIMITED PARTNERSHIP	0	0	43,355,266	43,355,266			10.81%
FOURTH CINVEN FUND (UBTI) LIMITED PARTNERSHIP	0	0	24,391,287	24,391,287			6.08%
FOURTH CINVEN FUND FCPR	0	0	20,068,168	20,068,168			5.00%
FOURTH CINVEN FUND CO-INVESTMENT PARTNERSHIP	0	0	2,229,797	2,229,797			0.56%
FOURTH CINVEN (MACIF) LIMITED PARTNERSHIP	0	0	638,063	638,063			0.16%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration Date

Exercise/Conversion Period/ Date

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument	Exercise price	Expiration date	Exercise/Conversion period	Number of voting rights instrument refers to	% of voting rights
					Nominal	Delta

Total (A+B+C)

Number of voting rights	% of voting rights
225,847,498	56.31

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

Cinven Limited acts as manager of the following entities:

Fourth Cinven Fund (No.1) Limited Partnership

Fourth Cinven Fund (NO.2) Limited Partnership

Fourth Cinven Fund (NO.3-VCOC) Limited Partnership

Fourth Cinven Fund (NO.4) Limited Partnership

Fourth Cinven Fund ND (UBTI) Limited Partnership

Fourth Cinven (MACIF) Limited Partnership,

together the "Cinven Funds".

The Cinven Funds and Fourth Cinven Fund Co-Investment Partnership are party to an agreement whereby Fourth Cinven Fund Co-Investment Partnership acts in accordance with the actions of the Cinven Funds, meaning that Cinven Limited also effectively controls Fourth Cinven Fund Co-Investment Partnership.

Cinven S.A. acts as manager of Fourth Cinven Fund FCPR.

Proxy Voting:

10. Name of the proxy holder:                                                                N/A

11. Number of voting rights proxy holder will cease to hold:        N/A

12. Date on which proxy holder will cease to hold voting rights: N/A

13. Additional information:

14. Contact name:

Anthony Dand, Interim Deputy Secretary, Spire healthcare Group plc

15. Contact telephone number:

+ 44 (0)20 7427 9092

 

END

 

 

HOLUVSRRSVABUAR